Breast Cancer News: Breaking Breast Cancer News, Comments and Articles. - Page: 2

Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer

University Heights,OH (PRWEB) May 23, 2013 Angeline Jolie’s brave decision to have both breasts removed based on the genetic study showing there was an 87% chance she would develop breast cancer is making women everywhere look at their odds o...

NAPBC accredits more than 500 breast centers

Today the National Accreditation Program for Breast Centers announced that it has now accredited more than 500 breast centers and the program has widespread distribution in 48 states including Alaska, Hawaii, and the territory of Puerto Rico.

Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer

In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results were published in Annals of Surgery Oncolog...

Investing in Cancer Research Is Worth the Risk: Echo He

If investigators could find a way to make breast cancer survivors truly cancer free, and if a diagnosis of pancreatic cancer were less dire, investors could reap windfalls while patients and their... Investors rely on us to share promising investmen...

Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Exemestane in Breast Cancer

CAMBRIDGE, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) announced today that the last patient has been enrolled in a Phase 2 randomized, double blind clinical trial of MM-121 in combination with exemestane in postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) and/or progesterone receptor positive (PR+), HER2-negative...

Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annual Meeting

SEATTLE, WA -- (Marketwired) -- 05/23/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, from May 31 through June 4, 2013. Atossa's exhibit will be located in booth 2019 at McCormick Place. The ForeCYTE Breast Health Test, developed and marketed...

Adherex Reports Feedback from the FDA from End of Phase 2 Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 05/23/13 -- Adherex Technologies Inc. (TSX: AHX)(OTCQB: ADHXF), today announced that it has received feedback from the FDA at an End-of-Phase 2 meeting held yesterday. During the FDA meeting, Adherex reviewed the opportunity that eniluracil offers to Metastatic Breast Cancer (MBC) patients who had rapid disease progression on capecitabin...

Reducing Your Risk Of Breast Cancer

Recently Angelina Jolie announced that she underwent a double mastectomy and reconstructive surgery in order to reduce her risk of developing breast cancer, she said she "hopes other women can benefit from my experience". When she found out what her...

Research identifies a way to make cancer cells more responsive to chemotherapy

(University of Western Ontario) Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western...

UEA scientists make breast cancer advance that turns previous thinking on its head

(University of East Anglia) Scientists at the University of East Anglia have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function.

Heavy Particle Beam Breast Cancer Treatment Trials Start At Japan National Institute Of Radiological Sciences

The Japan Institute of Radiological Sciences in Chiba prefecture has started clinical trials using heavy particle beam radiation against early breast cancer, the first treatment of its kind in Japan.

Dirty Girl Mud Run Coming to Kansas City

The Best and Biggest Mud Run for Women is Coming to Kansas City, KS on Saturday, June 22 Dirty Girl Mud Run, the original women-only national mud run series, is coming to the Kansas City area on Saturday, June 22. The event will be held at the National Agricultural Center & Hall of Fame (630 Hall of Fame Drive -- Bonner Springs, KS 66012)....

Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts

FARMINGTON, Conn., May 22, 2013 /PRNewswire-iReach/ -- World markets are constantly changing and developing. To stay aligned with the latest trends and events, companies now need a global business intelligence provider that can predict where an industry is headed next, so that they can adapt, react and evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099) Global Information Inc (GI...

Dirty Girl Mud Run Coming to Eastern PA

The Best and Biggest Mud Run for Women is Coming to Albrightsville, PA on Saturday, June 22 Dirty Girl Mud Run, the original women-only national mud run series, is coming to Eastern PA on Saturday, June 22. Over 3,700 women will participate at Skirmish USA (211 North Meckesville Rd. – Albrightsville, PA 18210). An untimed, wild...

Deficiency in Pregnancy

The nine months during a pregnancy and the months that follow during breast-feeding can place a number of physical, physiological and metabolic demands on women. With our nutritional and chemical balances often being disturbed during a time when it is so important that they are adequately maintained, obstetric studies often look at deficiencies during pregnancy. The impact of these deficiencies...

Angelina Jolie's double mastectomy and the question of who owns our genes

“Today it is possible to find out through a blood test whether you are highly susceptible to breast and ovarian cancer, and then take action,” the Oscar winning Hollywood actor Angelina Jolie said in...

Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC)

‒ Six presentations and sponsored lymphatic mapping symposium highlight results from Lymphoseek® clinical trials ‒ Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek® (technetium Tc 99m tilmanocept) Injection studies in...

UCLA Breast Cancer Drug Shows Promise

Breast cancer patients in a new UCLA trial are trying an experimental drug that is showing dramatic results in stopping the spread of cancer cells without the hair loss, nausea and vomiting associated with chemotherapy.

Nearly 35,000 New York City Babies Will Experience Colic This Year

NEW YORK, May 22, 2013 /PRNewswire/ -- Approximately 35,000 babies, or 28 percent of the more than 123,000 babies born in New York City this year, will be affected by colic, which is defined as unexplained crying three hours per day, three days per week, for at least three weeks.  Colief® Colic Council member and board-certified pediatrician, Robert Sears, M.D., co-author of the...

Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine

WORCESTER, Mass. and TORONTO, May 22, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced three presentations demonstrating the superiority of the AE37 breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the annual meeting of the American Socie...

Japan hospital tests powerful breast cancer therapy

A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, non-surgical, short-term radiation therapy for breast cancer.

Incredible Response to The Cold-Subfascial Breast AugmentaionTM Summer Subsidy Inspires Extention of the Subsidy to Include Mastopexy Augmentation and Implant Revision

Dr. Rian A. Maercks, the renowned Miami plastic surgeon of the self-named Maercks Institute, has been delivering beautiful results for years with his unique techniques. The Maercks Institute is now extending the incredible Cold-Subfascial Breast Augmentation Summer Subsidy to all mastopexy-augmentations and revision augmentations, allowing more women to benefit from these techniques (http://www.R...

Take an Inaugural Fundraising Cruise to Benefit Susan G. Komen(R)

CruisesOnly® and [Susan G. Komen® Team Up to Host a Group Cruise Sailing Wilmington, Mass. (PRWEB) May 22, 2013 CruisesOnly®, America’s Largest Cruise Agency and flagship brand in the World Travel Holdings portfolio, and Susan G. Komen® are teaming up to offer “A Cruise for the Cure®,” a unique [cruise fundraiser to raise money for breast cancer research, education,...

State of Alabama Crazy Chemo Hat Contest Fundraiser Benefiting United Cancer Survivors of America, Inc.

Fundraiser taking place across the state of Alabama to encourage current chemo patients and benefit United Cancer Survivors of America, Inc. Birmingham, Alabama (PRWEB) May 22, 2013 The Crazy Chemo Hat contest fundraiser is a unique fundraiser to benefit current chemo patients and United Cancer Survivors of America, Inc. nonprofit. The way the contest works is that friends of a current chemo pat...

Curie-Cancer and Roche strengthen partnership to fast-track the development of new molecules

Curie-Cancer and Roche build on four years partnership by increasing translational research programs, speeding up development of new cancer treatments   Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative efforts. In 2009, the Institut...